Ontology highlight
ABSTRACT:
SUBMITTER: Inoue S
PROVIDER: S-EPMC10407720 | biostudies-literature | 2023 Sep
REPOSITORIES: biostudies-literature
Inoue Shotaro S Win Kaung Htet Nay KHN Mon Cho Yee CY Fujikawa Tomoko T Hyodo Sayaka S Uemura Suguru S Ishida Toshiaki T Mori Takeshi T Hasegawa Daiichiro D Kosaka Yoshiyuki Y Nishimura Akihiro A Nakatani Naoko N Nino Nanako N Tamura Akihiro A Yamamoto Nobuyuki N Nozu Kandai K Nishimura Noriyuki N
Oncology letters 20230714 3
More than half of patients with high-risk neuroblastoma (HR-NB) experience relapse/regrowth due to the activation of chemoresistant minimal residual disease (MRD). MRD in patients with HR-NB can be evaluated by quantitating neuroblastoma-associated mRNAs (NB-mRNAs) in bone marrow (BM) and peripheral blood (PB) samples. Although several sets of NB-mRNAs have been shown to possess a prognostic value for MRD in BM samples (BM-MRD), MRD in PB samples (PB-MRD) is considered to be low and difficult to ...[more]